Polymorphisms of mitochondrial DNA and mortality in sepsis. Have we found the needle in the haystack?;Polimorfismos del ADN mitocondrial y mortalidad en la sepsis. ¿Hemos hallado la aguja en el pajar?

Medicina Intensiva

Volumn 31, Issue 4, 2007, Pages 184-186

  Garnacho Montero, J ^a   Garnacho Montero, C ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MITOCHONDRIAL DNA; TUMOR NECROSIS FACTOR;

DNA POLYMORPHISM; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HAPLOTYPE; HEMODYNAMICS; MORTALITY; NEEDLE; NOTE; SEPSIS; SEPTIC SHOCK;

EID: 34347342926     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(07)74804-0     Document Type: Article

References (23)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated cost of care. Crit Care Med. 2001;29:1303-10.
2. Garnacho-Montero J, García-Garmendia JL, Barrero-Almodovar A, Jiménez-Jiménez FJ, Pérez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742-51.
3. Stuber F, Petersen M. Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med. 1996;24:381-4.
4. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-α promoter polymorphism, with septic shock susceptibility and mortality. JAMA. 1999;281:1919-26.
5. Rauchschwalbe SK, Maseizik T, Mittelkotter U, Schluter B, Patzig C, Thiede A, et al. Effect of the LT-alpha (+250 G/A) polymorphism on markers of inflammation and clinical outcome in critically ill patients. J Trauma. 2004;56:815-22.
6. Gordon AC, Lagan AL, Aganna E, Cheung L, Peters CJ, McDermott MF, et al. TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immunity. 2004;5:631-40.
7. Waterer GW, Quasney MW, Cantor RM, Wunderink RG. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Resp Crit Care Med. 2001;163:1599-604.
8. Gallagher PM, Lowe G, Fitzgerald T, Bella A, Greene CM. McElvaney NG, et al. Association of 11-10 polymorphism with severity of illness in community acquired pneumonia. Thorax. 2003;58:154-6.
9. Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med. 2002;30:969-73.
10. Sutherland AM, Walley KR, Russel JA. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med. 2005;33:638-44.
11. Arnalich F, López-Maderuelo D, Codoceo R, López J, Solis-Garrido LM, Capiscol C, et al. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol. 2002;127:331-6.
12. Fang XM, Schroder S, Hoeft A, Stuber F. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med. 1999;7:1330-4.
13. Lowe PR, Galley HF, Abdel-Fattah A, Webster NR. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med. 2003;31:34-8.
14. Reid CL, Perrey C, Pravica V, Hutchinson IV, Campbell IT. Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome. Crit Care Med. 2002;30:2216-21.
15. Sutherland AM, Walley KR, Manocha S, Russell JA. The association of interleukin 6 haplotype clades with mortality in critically ill adults. Arch Inter Med. 2005;165:78-82.
16. Wattanathum A, Manocha S, Groshau HS, Russel JAI, Walley KR. Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest. 2005;128: 1690-8.
17. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003;348:2656-68.
18. Ruiz-Pesini E, Lapeña AC, Díez-Sánchez C, Pérez-Martos A, Montoya J, Álvarez E, et al. Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet. 2000;67:682-96.
19. Baudouin S, Saunders D, Tiangyou W, Elson J, Poynter J, Pyle A, et al. Mitochondrial DNA and survival after sepsis: a prospective study. Lancet. 2005;366:2118-21.
20. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. JAMA. 1997; 277:1058-63.
21. Calvano SE, Xiao W, Richards DR. Felciano RM, Baker HV, Cho RJ, et al. A net-work analysis of systemic inflammation in humans. Nature. 2005;437:1032-7.
22. Sutherland AM, Russell JA. Issue with polymorphism analysis in sepsis. Clin Infect Dis. 2005;41:S396-402.
23. Freeman BD, Buchmann TG. Gene in a hay stack: tumor necrosis factor polymorphism and outcome in sepsis. Crit Care Med. 2000;28:3090-1.